Next Fund Manager
Matt McNamara – CIO & Board Director, Horizon 3 Biotech
Matt is a specialist in human healthcare technology and is passionate about investing in the commercialisation of this industry. He has spent more than 30 years in the healthcare and medical sciences sector and has more than 20 years’ experience as a venture capitalist. Matt has served as the CIO at BioScience Managers ($200m FUM, >20% IRR), CEO of SciCapital pre-seed fund, SVP Business Development for eBioinformatics Inc and has an exciting portfolio of executive/non-executive board and advisory roles.
Meet the Manager
Get access to some of Australia’s leading fund managers who share their 3 favourite stocks, investment approach and insights on the market.
Each session includes:
- 3 favourite stock opportunities
- Market views for the year ahead
- Investment strategy and approaches
This is a live and interactive session, where you get the rare opportunity for Q&A with a fund manager. Spots are limited – book now to access this FREE event.
Ron Shamgar TAMIM Asset Management
Ron Shamgar is the Head of Australian Equity Strategies at TAMIM Asset Management and is also the manager of the TAMIM Australian Equity All Cap Fund. Ron is responsible for research, company analysis, portfolio construction and marketing the Fund.
Craig Scheef Technical Investing
Craig has over 30 years experience working with and analysing public companies, including over 20 years directly managing portfolios for clients. He has an open-minded approach and methodology that has enabled him to identify significant themes and trends before the majority of investors move in
Lee IaFraté Armytage Private Limited
Lee is the Executive Chairman of Armytage Private and is responsible for portfolio management of the Armytage Individually Managed Account (IMA) Service, sector & stock analysis, the Armytage Micro Cap Activist Fund as well as equity and option dealing.